Benny Johnson

2.5k total citations
79 papers, 888 citations indexed

About

Benny Johnson is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Benny Johnson has authored 79 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 26 papers in Cancer Research and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Benny Johnson's work include Colorectal Cancer Treatments and Studies (42 papers), Cancer Genomics and Diagnostics (26 papers) and Genetic factors in colorectal cancer (23 papers). Benny Johnson is often cited by papers focused on Colorectal Cancer Treatments and Studies (42 papers), Cancer Genomics and Diagnostics (26 papers) and Genetic factors in colorectal cancer (23 papers). Benny Johnson collaborates with scholars based in United States, Canada and Belgium. Benny Johnson's co-authors include Daruka Mahadevan, Scott Kopetz, Van K. Morris, Steve Warren, Chris Otto, Aleksandar Milenković, Emil Jovanov, Pleun de Groen, Michael J. Overman and Kanwal Raghav and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Benny Johnson

74 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benny Johnson United States 16 501 213 198 182 146 79 888
Juan Zhou China 16 331 0.7× 94 0.4× 305 1.5× 142 0.8× 126 0.9× 74 837
Ji Hyung Hong South Korea 17 274 0.5× 50 0.2× 230 1.2× 209 1.1× 159 1.1× 59 920
Jin Roh South Korea 18 430 0.9× 140 0.7× 169 0.9× 348 1.9× 171 1.2× 71 1.2k
M Mousseau France 16 454 0.9× 84 0.4× 247 1.2× 170 0.9× 87 0.6× 55 823
Kazem Anvari Iran 15 283 0.6× 60 0.3× 216 1.1× 398 2.2× 275 1.9× 82 1.0k
Hui Zeng China 17 357 0.7× 62 0.3× 168 0.8× 397 2.2× 125 0.9× 61 1.1k
Lei Luo China 16 240 0.5× 28 0.1× 216 1.1× 216 1.2× 251 1.7× 46 819
Michael P. Manos United States 13 933 1.9× 54 0.3× 224 1.1× 315 1.7× 128 0.9× 39 1.3k
Meng Wu China 16 163 0.3× 80 0.4× 66 0.3× 121 0.7× 110 0.8× 59 829
Seth S. Katz United States 15 358 0.7× 76 0.4× 195 1.0× 124 0.7× 170 1.2× 27 837

Countries citing papers authored by Benny Johnson

Since Specialization
Citations

This map shows the geographic impact of Benny Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benny Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benny Johnson more than expected).

Fields of papers citing papers by Benny Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benny Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benny Johnson. The network helps show where Benny Johnson may publish in the future.

Co-authorship network of co-authors of Benny Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Benny Johnson. A scholar is included among the top collaborators of Benny Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benny Johnson. Benny Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Benny, et al.. (2026). Racial, Ethnic, and Socioeconomic Survival Disparities in Early-Onset Metastatic Colorectal Cancer. JAMA Network Open. 9(1). e2553146–e2553146.
2.
Wilky, Breelyn A., Gary K. Schwartz, Michael S. Gordon, et al.. (2025). Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas. Journal of Clinical Oncology. 43(11). 1358–1368. 9 indexed citations
3.
Thomas, Jane V., Kaysia Ludford, Jason Willis, et al.. (2023). Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination. Cancer Research Communications. 3(12). 2510–2517. 4 indexed citations
4.
Napolitano, Stefania, Aparna R. Parikh, Jason T. Henry, et al.. (2023). Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing. JCO Precision Oncology. 7(7). e2300228–e2300228. 1 indexed citations
5.
Morris, Van K., Haifeng Zhu, Xiaoling Li, et al.. (2023). P-230 Biomarkers associated with survival benefit to atezolizumab and bevacizumab for treatment of metastatic anal cancer. Annals of Oncology. 34. S97–S97. 1 indexed citations
6.
Rogers, Jane E., Michael Leung, Van K. Morris, et al.. (2023). Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach. Cancers. 15(15). 3890–3890. 1 indexed citations
7.
Jácome, Alexandre A. & Benny Johnson. (2023). Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?. Cells. 12(7). 1068–1068. 8 indexed citations
8.
Morris, Van K., Amir A. Jazaeri, Shannon N. Westin, et al.. (2023). Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers. The Oncologist. 28(7). 618–623. 13 indexed citations
9.
Konishi, Tsuyoshi, Harmeet Kaur, Y. Nancy You, et al.. (2023). Immunotherapy for localized MSI-H colorectal cancer: Characterizing endoscopic and imaging response.. Journal of Clinical Oncology. 41(16_suppl). 3610–3610. 1 indexed citations
10.
Sorokin, Alexey V., Preeti Kanikarla Marie, Ganiraju C. Manyam, et al.. (2022). Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6. Cancer Research. 82(18). 3335–3344. 37 indexed citations
11.
Rogers, Jane E., Hyunsoo Hwang, Wei Qiao, et al.. (2022). Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience. The Oncologist. 27(11). 952–957. 14 indexed citations
12.
Holliday, Emma B., Van K. Morris, Benny Johnson, et al.. (2022). Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. The Oncologist. 27(1). 40–47. 12 indexed citations
13.
Ludford, Kaysia, Kanwal Raghav, Mariela A. Blum Murphy, et al.. (2021). Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 2520–2520. 8 indexed citations
14.
Rogers, Jane E. & Benny Johnson. (2021). The reality of early-onset colorectal cancer: highlighting the needs in a unique but emerging population. PubMed. 4. 63–63. 9 indexed citations
15.
Catenacci, Daniel V.T., Steven B. Maron, Benjamin Solomon, et al.. (2021). 960MO Clinical outcomes and immune responses in a phase I/II study of personalized, neoantigen-directed immunotherapy in patients with advanced MSS-CRC, GEA and NSCLC. Annals of Oncology. 32. S830–S831. 5 indexed citations
16.
Chu, Jenny E., Benny Johnson, Van K. Morris, et al.. (2020). Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis. Clinical Cancer Research. 26(17). 4599–4605. 31 indexed citations
17.
Mendis, Shehara, Miguel Alcaide, James T. Topham, et al.. (2020). Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer. Clinical Colorectal Cancer. 19(2). 132–136.e3. 1 indexed citations
18.
Henry, Jason T. & Benny Johnson. (2019). Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer. Chinese Clinical Oncology. 8(5). 49–49. 22 indexed citations
19.
Giri, Smith, Benny Johnson, David L. McCormick, et al.. (2015). Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis. Leukemia Research. 39(12). 1342–1346. 23 indexed citations
20.
Putnam, Joe B., et al.. (2004). Cancer pain: surgical/radiological. Journal of Pain. 5(3). S50–S50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Zhou Breakdown of academic impact, for papers by Ji Hyung Hong Breakdown of academic impact, for papers by Jin Roh Breakdown of academic impact, for papers by M Mousseau Breakdown of academic impact, for papers by Kazem Anvari Breakdown of academic impact, for papers by Hui Zeng Breakdown of academic impact, for papers by Lei Luo Breakdown of academic impact, for papers by Michael P. Manos Breakdown of academic impact, for papers by Meng Wu Breakdown of academic impact, for papers by Seth S. Katz
Rankless by CCL
2026